Coronamic acid (CMA; 2-ethyl-1-aminocyclopropane 1-carboxylic acid) is an intermediate in the biosynthesis of coronatine (COR), a chlorosis-inducing phytotoxin produced by Pseudomonas syringae pv. glycinea PG4180. Tn5 mutagenesis and substrate feeding studies were previously used to characterize regions of the COR biosynthetic gene cluster required for synthesis of coronafacic acid and CMA, which are the only two characterized intermediates in the COR biosynthetic pathway. In the present study, additional Tn5 insertions were generated to more precisely define the region required for CMA biosynthesis. A new analytical method for CMA detection which involves derivatization with phenylisothiocyanate and detection by high-performance liquid chromatography (HPLC) was developed. This method was used to analyze and quantify the production of CMA by selected derivatives of P. syringae pv. glycinea which contained mutagenized or cloned regions from the CMA biosynthetic region. pMU2, a clone containing a 6.45-kb insert from the CMA region, genetically complemented mutants which required CMA for COR production. When pMU2 was introduced into P. syringae pv. glycinea 18a/90 (a strain which does not synthesize COR or its intermediates), CMA was not produced, indicating that pMU2 does not contain the complete CMA biosynthetic gene cluster. However, when two plasmid constructs designated pMU234 (12.5 kb) and pKTX30 (3.0 kb) were cointroduced into 18a/90, CMA was detected in culture supernatants by thin-layer chromatography and HPLC. The biological activity of the CMA produced by P. syringae pv. glycinea 18a/90 derivatives was demonstrated by the production of COR in cosynthesis experiments in which 18a/90 transconjugants were cocultivated with CMA-requiring mutants of P. syringae pv. glycinea PG4180. CMA production was also obtained when pMU234 and pKTX30 were cointroduced into P. syringae pv. syringae Bi; however, these two constructs did not enable Escherichia coli K-12 to synthesize CMA. The production of CMA in P. syringae strains which lack the COR biosynthetic gene cluster indicates that CMA production can occur independently of coronafacic acid biosynthesis and raises interesting questions regarding the evolutionary origin of the COR biosynthetic pathway.
vars including glycinea, atropurpurea, morsprunorum, tomato, and maculicola (17, 19, 30) . COR induces a number of responses in host plants which can be reproduced by ethylene or indoleacetic acid, suggesting that the toxin alters host metabolism in a manner analogous to that of plant growth hormones (9, 13, 25) .
COR consists of two distinct moieties, coronafacic acid (CFA) and coronamic acid (CMA), which are derived from separate biosynthetic pathways. CFA, which is derived from the polyketide pathway (23) , is coupled via amide bond formation to CMA, a cyclized derivative of isoleucine (18) (Fig. 1) . Unequivocal evidence for the role of CMA (2-ethyl-1-aminocyclopropane 1-carboxylic acid) as a distinct intermediate in the COR biosynthetic pathway was recently obtained (20) . The biosynthetic block to COR in several mutants was eliminated when CMA was exogenously supplied, whereas other mutants were shown to secrete CMA when the coupling step or CFA biosynthesis was blocked (3, 20) . Additional studies with strain G70, a coupling-defective (CPL-) mutant which secretes result would be predicted only if CMA was a true pathway intermediate and the preferred substrate for coupling to CFA.
The genes for COR biosynthesis in strain PG4180 are encoded within a 30-kb region of a 90-kb plasmid designated p4180A (6, 31) . Extensive mutagenesis with Tn5 and phenotypic characterization of each mutation resulted in the recovery of mutants blocked in distinct biosynthetic steps (3) . The present study has focused on the localization of the CMA biosynthetic gene cluster. To facilitate our genetic studies, a simple and sensitive method for the detection and quantification of CMA by using reverse-phase high-performance liquid chromatography (HPLC) was developed. Additional Tn5 mutants of PG4180 were generated to more precisely define the DNA region required for CMA biosynthesis, and selected mutants were analyzed for CMA biosynthesis. These results were used to successfully clone the CMA biosynthetic region and produce CMA in two P. syringae strains which lack all parts of the COR biosynthetic gene cluster.
MATERUILS AND METHODS
Bacterial strains, plasmids, and growth conditions. The bacterial strains and plasmids used in this work are listed in FIG. 1. Biochemical pathways involved in the synthesis of COR in P. synngae pv. glycinea PG4180. The structure of COR consists of a polyketide component, CFA, coupled via amide bond formation to an amino acid component, CMA. CFA is synthesized as a branched polyketide from five acetate units and one pyruvate unit via an unknown sequence of events (23) . CMA is derived from isoleucine via alloisoleucine and cyclized by an unknown mechanism (18, 20, 22) . Available evidence indicates that the intermediates CFA and CMA are coupled in the final step of the biosynthetic pathway. Table 1 . Pseudomonas strains were routinely cultured on King's medium B (14) or mannitol-glutamate medium (11) at 24 to 26°C. Escherichia coli HB101 and DH5cx (16) were used as hosts in cloning experiments and were cultured in LuriaBertani medium at 37°C. E. coli K-12 (16) was maintained on Luria-Bertani medium prior to studies involving CMA biosynthesis. Strains assayed for CMA production were cultivated in Hoitink-Sinden medium optimized for COR production (HSC) (21) . Antibiotics were added to media in the following concentrations: tetracycline, 12.5 jig/ml; kanamycin, 10 ,ug/ml; ampicillin, 40 j,g/ml; and streptomycin, 25 ,ug/ml. Molecular genetic techniques. Agarose gel electrophoresis, DNA restriction digests, ligation reactions, transformations, and Southern hybridizations were performed by using standard procedures (16) . When specific DNA fragments were excised from agarose gels, residual agarose was removed with the Qiaex DNA Extraction Kit manufactured by Qiagen (Chatsworth, Calif.).
Plasmid DNA was isolated from E. coli by standard procedures (16) and from P. syringae as described previously (4, 8) . Selected clones were mobilized from E. coli into P. syringae by using the helper plasmid pRK2013 (6) , and transconjugants were verified by agarose gel electrophoresis. TnS insertions in p4180A were generated by marker exchange as described elsewhere (31) .
The construction of pMU2, pMU23, and pMU234 involved the partial digestion of pSAY10 with SstI, religation, and recovery of Tcr E. coli transformants containing SstI fragments as shown in Fig. 2 Analysis of coronafacoyl compounds. P. syringae strains were analyzed for production of coronafacoyl compounds (COR, CFA, and CFA-amino acid conjugates) in 7-day, 10-ml cultures grown in HSC at 18°C with 280 rpm on a rotary shaker. Coronafacoyl compounds were recovered as organic acids from culture supernatants and analyzed by HPLC as described previously (21) . When necessary, organic acids were extracted from 600 ml (60 x 10 ml) of culture supernatant by methods described elsewhere (5) .
Isolation and detection of CMA. Bacteria were cultured in 600 ml (60 x 10 ml) of HSC at 18°C for 7 days (P. syringae) or 24°C for 5 days (E. coli K-12). Cells were pelleted by centrifugation at 6,800 x g for 10 min, and supernatants were stored at 4°C. Free amino acids were isolated from bacterial supernatants by ion exchange on Amberlite resin CG-120 (30 g; Sigma Chemical Co., St. Louis, Mo.) which was freshly converted to the H+ form as described previously (20) . Residues were then dissolved in methanol (1 ml) and stored at 4°C for further analysis.
For thin-layer chromatography (TLC), 10-,ul samples were applied to Sigmacell Type 100 plates (20 by 20 cm; Sigma Chemical Co.) in 10-mm bands, air dried, and then developed in a solution containing n-butanol, acetic acid, water, and pyridine in a 5:1:4:4 ratio (20) . Plates were visualized (20) by being sprayed with a ninhydrin-cadmium acetate solution (1 g of ninhydrin, 0.1 g of cadmium acetate, 0.5 ml of acetic acid, Pico-Tag C-18 reverse-phase column (3.9 by 100 mm), and detector model 490. Phenylthiocarbamyl (PTC) derivatives were dissolved in sample diluent (5 mM sodium phosphate, 5% acetonitrile [pH 7.4]), filtered through 0.45-,um-pore-size, 3-mm-diameter nylon filters (Micron Separations, Inc., Westboro, Mass.), and then injected in 10-plI volumes. PTC derivatives were selectively eluted from the column with a binary gradient consisting of an aqueous phase of 140 mM sodium acetate-trihydrate (with 6% acetonitrile-0.05% triethylamine [pH 6.4]) and an organic phase of 60% acetonitrile (7) . PTC derivatives were detected by measuring the A254. The total time for separation of the derivatives and reequilibration of the column was 22 min. Data were collected and processed with the Baseline 810 software package.
Authentic CMA was produced by acid hydrolysis of COR according to the method of Ferguson and Mitchell (9) . The product after TLC produced the typical yellow spot after ninhydrin treatment. This product retained biological activity, since it restored COR production to mutants which required CMA for COR biosynthesis (3, 31) . A calibration curve for CMA was constructed by injecting a dilution series of CMA at concentrations ranging from 50 to 750 pmol, measuring the A254, and calibrating the HPLC by using Waters Baseline 810 chromatography software. Quantitative information concerning CMA yields was then obtained from the calibration curve.
Cosynthesis experiments. Conditions for the inoculation and incubation of strains utilized in cocultivation studies have been described previously (3, 31) . In preliminary experiments, strains derived from P. syringae pv. glycinea 18a/90 showed a higher growth rate than mutants derived from PG4180. There- (S) . Functional regions of the COR biosynthetic cluster are shown in the boxed areas above the map. TnS insertions in the regions designated wild type had no affect on COR production. Mutants containing mutations with the prefix C (see the shaded box) were COR-CMA-CFA+ CPL+; these were utilized in the genetic complementation studies described in the text. Mutants containing mutations with the prefix N were generated in this study and were used to define the left border of the COR biosynthetic gene cluster. All other mutations (labelled and unlabelled) have been described previously (3, 31) . CPL, coupling activity.
fore, HSC broth was first inoculated with a PG4180 mutant, incubated for 24 h, and then supplemented with a second strain derived from 18a/90. This procedure compensated for the higher growth rate of 18a/90 and resulted in optimal growth of both strains utilized in the cocultivation experiments. Organic acids were extracted after a 7-day incubation and analyzed for production of coronafacoyl compounds as outlined above.
RESULTS
Detection of CMA by HPLC. Previous HPLC separation and detection conditions for CFA and COR were not suitable for CMA, since CMA does not absorb strongly at 208 nm, the maximum UV for COR. However, PTC derivatization of the amino group of CMA allowed efficient detection at 254 nm. PTC derivatives of CMA eluted at approximately 8.53 min (Fig. 3C) and were clearly distinguishable when cochromatographed with amino acid standards (Fig. 3A and B) . These results indicated that CMA does not coelute with any of the 17 amino acids tested and can be differentiated in a mixture of amino acids. The elution time of CMA (8.53 min) was highly reproducible (+ 0.05 min) in five different experiments consisting of four to eight replications (data not shown). This reproducibility was established regardless of whether CMA was measured separately or in combination with other amino acids.
The calibration curve for CMA (Fig. 4) was linear in the range of 50 to 750 pmol, permitting a precise quantification of CMA. Quantities of CMA as low as 10 pmol per injection were detected by this method. Differences in the quantities of CMA detected in purified samples subjected to ultrafiltration and/or ion-exchange chromatography were also investigated. The loss of CMA due to ultrafiltration was negligible, and only 10% of the CMA was unaccounted for after ion-exchange chromatography and ultrafiltration (data not shown). These results verify the accuracy of this detection method for quantifying levels of CMA.
Genetic complementation of CMA-requiring mutants. Mutants PG4180.C14, PG4180.CO, PG4180.C1, and PG4180.C9 were previously shown to be CFA+ CPL+ CMA-, and they required the addition of exogenous CMA for COR production (3, 31) . Initial attempts at defining the region(s) required for CMA biosynthesis were focused on genetically complementing these mutants with DNA from the COR biosynthetic cluster. Since the Tn5 insertions designated C14, CO, Cl, and C9 mapped within SstI fragment 2 (Fig. 2) , pSAY10.11, which contains SstI fragment 2 subcloned in pRK415, was introduced into PG4180.CO and PG4180.C9, and the transconjugants were analyzed for COR production. PG4180.CO and PG4180.C9 transconjugants containing pSAY10.11 did not produce COR, indicating that SstI fragment 2 (4.8 kb) was not sufficient to restore CMA biosynthesis to these mutants. pMUB4, pMUE29, and pMUP31, which contained inserts of 4.0, 2.9, and 3.1 kb, respectively (Fig. 2) , also failed to complement the four CMA-requiring mutants. However, pSAY10, which contains a 29-kb insert from the COR biosynthetic cluster, enabled all four CMA-requiring mutants to synthesize COR. These results indicated that additional DNA adjacent to SstI fragment 2 was required to complement the CMA-defective mutants. This hypothesis was investigated by introducing pMU2, which contains SstI fragment 2 and most of SstI fragment 1, into the four CMA-requiring mutants. The introduction of pMU2 into all four mutants resulted in the synthesis of COR, indicating that the biosynthetic block to CMA in these mutants was relieved by the introduction of pMU2. HPLC tracings supporting these results for PG4180.CO and the transconjugant PG4180.CO(pMU2) are shown in Fig. 5 . CMA biosynthesis by P. syringae pv. glycinea 18a/90. P. syringae pv. glycinea 18a/90 was previously reported to be a nonproducer of COR, and it was found to lack DNA homologous to the COR gene cluster by means of Southern hybridization experiments (29) . In the present study, supernatants of 18a/90 were shown by HPLC analyses to be devoid of both CFA and coronafacoyl compounds and were shown by TLC and HPLC not to contain CMA. Furthermore, substrate feeding assays using exogenous CFA and CMA indicated that 18a/90 could not ligate CFA and CMA to form COR and therefore that it lacked coupling activity (i.e., it was CPL-). Therefore, since 18a/90 had no biosynthetic activity in the COR pathway, several constructs from the COR biosynthetic gene cluster were introduced into it to determine the DNA region required for CMA biosynthesis. The amino acids iso- 90(pSAY12) and 18a/90(pMU234, pKTX30) contained an amino acid which comigrated with authentic CMA on TLC plates (data not shown), and the presence of CMA in these extracts was confirmed by HPLC analysis (Fig. 6B) . HPLC analysis of supernatants from the 18a/90 wild type (Fig. 6A) and all other 18a/90 derivatives demonstrated an absence of CMA. These results provided unequivocal evidence that plasmids pMU234 and pKTX30 contain all of the DNA necessary for expression of CMA biosynthesis in P. syringae pv. glycinea 18a/90.
CMA biosynthesis in other bacterial strains. Cosmid pSAY12 as well as plasmids pMU234 and pKTX30 was introduced into P. syringae pv. syringae Bi, a CFA-CMA-CPL-nonproducer of COR, and into E. coli K-12, which lacks the COR biosynthetic gene cluster. Amino acids were isolated from 500-ml cultures of P. syningae pv. syringae Bi, E. coli K-12, and selected transconjugants and analyzed by TLC and HPLC. CMA production was detected in P. syringae pv. a The maintenance of the constructs in 18a/90 required the addition of tetracycline to the fermentation. Therefore, PG4180 mutants contained pRK415 (Tcr) as a source of tetracycline resistance.
b COR was detected by HPLC analysis of organic acids extracted from supematants of the cocultivation. +, COR detected; -, no COR detected. cC14, PG4180.C14; CO, PG4180.CO; Cl, PG4180.C1; C9, PG4180.C9.
syringae Bl(pSAY12) and Bl(pMU234, pKTX30) but not in E. coli K-12 derivatives containing these same constructs. CMA was not detected in either wild-type strain (P. syringae pv. syringae B1 or E. coli K-12). Cosynthesis experiments. Cosynthesis studies generally involve the growth of two defined strains which individually lack the ability to make the end product of interest. The production of the biosynthetic end product in the cocultivation indicates that an intermediate has been produced by one strain, secreted, and utilized by the second strain to produce the end product. Feeding experiments had previously shown that exogenous CMA could be taken up by CFA+ CPL+ CMAmutants of PG4180 and used to synthesize COR (3). Consequently, the cocultivation experiments conducted in the present study were designed to screen for the biological activity of the CMA produced by derivatives of 18a/90. The secretion of CMA by 18a/90 derivatives would be indicated by the production of COR in the cocultivation, indicating that the CFA+ CPL+ CMA-mutants of PG4180 had assimilated CMA and utilized it to synthesize COR.
The results for the cocultivation experiment are summarized in Table 2 . COR was synthesized in significant quantities when the four CMA-CFA+ CPL+ mutants, PG4180.C14, PG4180.CO, PG4180.C1, and PG4180.C9, were cocultivated with P. syringae pv. glycinea 18a/90(pSAY12). However, other combinations did not result in COR synthesis. P. syringae pv. glycinea 18a/90(pMU234, pKTX30) was not tested in these experiments.
Identification of the left border of the COR biosynthetic gene cluster in PG4180. Genetic complementation studies with CMA-requiring mutants and the production of CMA by P. syringae pv. glycinea 18a/90(pKTX30, pMU234) indicated that the region required for CMA biosynthesis extended further leftward of SstI fragment 2. To more precisely define the left border of the CMA biosynthetic gene cluster, pMUH72, which contains a 7.2-kb Hindlll fragment (Fig. 2) , was saturated with TnS insertions. Tn5 insertions in p4180A were generated by homologous recombination using various pMUH72::TnS constructs as described previously (31) . Southern blot analysis of intact and digested plasmid DNA was used to confirm the locations of the Tn5 insertions in p4180A (mutations with the prefix N in Fig. 2 (Table 3) . Therefore, the results shown in Table 3 (20) . In contrast, CFA, the end product of the polyketide pathway to COR, is generally secreted with COR and can be detected in organic acid extracts (3, 31) . In the present study, reversephase HPLC was used to accurately determine the concentrations of CMA in bacterial supernatants. syringae.
The lack of CMA production in E. coli K-12 was not surprising, since previous efforts aimed at expressing the coupling function in K-12 also failed (15) . Although the reason for the lack of expression is not clear, failure to transcribe the CMA biosynthetic cluster remains a possibility, since Pseudomonas promoters are often not efficiently recognized in E. coli.
In the current study, CMA was produced and expressed independently of the CFA biosynthetic cluster. Previous studies with blocked mutants indicated that CFA biosynthesis could occur without CMA production. This raises interesting questions regarding the evolutionary origin of the COR biosynthetic pathway and whether production of CMA and production of CFA might occur independently in nature. Although neither CMA nor CFA causes chlorosis in plant hosts, these compounds may individually possess properties which benefit bacteria that produce them in undetermined ways.
The specific steps involved in CMA biosynthesis remain the subject of ongoing investigations. Parry et al. (22) demonstrated that alloisoleucine is a more immediate precursor to CMA than isoleucine is, which suggests that alloisoleucine functions as an intermediate in the CMA pathway. Experimental evidence is consistent with the oxidative cyclization of L-alloisoleucine to form CMA (24) . For this cyclization to produce CMA, the CMA synthetase enzyme or enzyme complex would have to perform at least four different reactions: (i) recognition and binding of isoleucine; (ii) isomerization to alloisoleucine; (iii) oxidative cyclization; and (iv) release of CMA from the enzyme complex. In this respect, a large transcript which encodes several enzymes or a multifunctional protein fits the hypothetical scheme. Comparable processes in the biosynthesis of clavaminic acid (26) , isopenicillin N (2), and deacetoxycephalosporin C (2) have been uncovered. Although the substrates for the enzymes which synthesize these compounds are different, they resemble each other and the puta-APPL. ENVIRON. MICROBIOL.
on November 7, 2017 by guest http://aem.asm.org/ Downloaded from tive CMA synthetase in several respects: isomerization of a precursor, oxidative cyclization, formation of a cyclic molecule of high intramolecular energy, and antimicrobial or biological activity of the end product. Certainly, nucleotide sequencing of the cloned DNA region derived from this study will reveal new insights regarding related enzymes or enzyme families and thus will provide the keys to elucidating the actual mechanisms leading to the synthesis of CMA.
